Capwell Pharmaceuticals Private Limited
About Capwell Pharmaceuticals Private Limited
Data last updated:
Capwell Pharmaceuticals Private Limited is a private limited company based in Faizabad, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2019PTC122549. Its GSTIN is 09AAICC4337M1Z9 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Pragya Srivastav and Akanksha Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 510 Khandari Bazar, Faizabad, Uttar Pradesh, India – 224001.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.52 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹13,737 (net margin 0.4%) and EBITDA of ₹31,413 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years.
Company details
Contact details
Capwell Pharmaceuticals Private Limited's registered office is in Faizabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 510 Khandari Bazar, Faizabad, Uttar Pradesh, India – 224001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Capwell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Capwell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Capwell Pharmaceuticals Private Limited, buy the company report.
Financials of Capwell Pharmaceuticals Private Limited
FY 2025 filings availableCapwell Pharmaceuticals Private Limited reported revenue of ₹33.52 Lakh (down 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹31,413 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,737 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Capwell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Capwell Pharmaceuticals Private Limited
Capwell Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pragya Srivastav | Director | 25 Jan 2020 | 6 Years 9 Months | Current |
| Akanksha Srivastava | Director | 19 Oct 2019 | 7 Years 0 Months | Current |
| Alok Kumar Srivastava | Director | 19 Oct 2019 | 7 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Capwell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Capwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Capwell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC4337M1Z9 | Uttar Pradesh | Active | 22 Jun 2020 |
To see the full GST registrations and return filing status of Capwell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Capwell Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Pragya Srivastav was appointed as Director on 25 Jan 2020.
Frequently asked questions
Capwell Pharmaceuticals is an active private limited company based in Faizabad, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 October 2019 (7+ years old) and is registered under CIN U24290UP2019PTC122549.
Capwell Pharmaceuticals has 3 current directors:
- Pragya Srivastav - Director
- Akanksha Srivastava - Director
- Alok Kumar Srivastava - Director
The latest financial statements of Capwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Capwell Pharmaceuticals is 09AAICC4337M1Z9, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Capwell Pharmaceuticals is U24290UP2019PTC122549. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Capwell Pharmaceuticals was incorporated on 19 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
Pragya Srivastav was appointed as Director on 25 Jan 2020. Akanksha Srivastava was appointed as Director on 19 Oct 2019. Alok Kumar Srivastava was appointed as Director on 19 Oct 2019.
The registered office of Capwell Pharmaceuticals is at H.No. 510 Khandari Bazar, Faizabad, Uttar Pradesh, India – 224001.
Capwell Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Capwell Pharmaceuticals can be reached at its registered office: H.No. 510 Khandari Bazar, Faizabad, Uttar Pradesh, India – 224001.